1147423-20-8 Usage
Uses
Used in Pharmaceutical Manufacturing:
2,7-Diazaspiro[4.4]nonane-2-carboxylic acid, 1,1-diMethylethyl ester, hydrochloride is used as a pharmaceutical intermediate for the synthesis of various medications. Its unique chemical structure and properties contribute to the development of new drugs with different therapeutic effects.
Used in Drug Synthesis:
In the pharmaceutical industry, 2,7-Diazaspiro[4.4]nonane-2-carboxylic acid, 1,1-diMethylethyl ester, hydrochloride is utilized as a key component in the synthesis of a wide range of medications. Its chemical properties allow for the creation of diverse pharmaceutical products with potential applications in treating various health conditions.
Used in Research and Development:
2,7-Diazaspiro[4.4]nonane-2-carboxylic acid, 1,1-diMethylethyl ester, hydrochloride is employed as a research compound in the scientific community. Its unique properties make it a valuable tool for studying the mechanisms of drug action and developing new therapeutic strategies.
Used in Drug Formulation:
In the pharmaceutical industry, 2,7-Diazaspiro[4.4]nonane-2-carboxylic acid, 1,1-diMethylethyl ester, hydrochloride is used in the formulation of various drug products. Its enhanced stability and water solubility make it easier to incorporate into different dosage forms, ensuring consistent drug delivery and improved patient compliance.
Check Digit Verification of cas no
The CAS Registry Mumber 1147423-20-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,4,2 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1147423-20:
(9*1)+(8*1)+(7*4)+(6*7)+(5*4)+(4*2)+(3*3)+(2*2)+(1*0)=128
128 % 10 = 8
So 1147423-20-8 is a valid CAS Registry Number.
1147423-20-8Relevant academic research and scientific papers
NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
-
Page/Page column 90, (2008/06/13)
The invention provides compounds of general formula (I) wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
